A ten-year evolution of a multidrug- resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni.

Slides:



Advertisements
Similar presentations
Lecture 2 Strachan and Read Chapter 13
Advertisements

applications of genome sequencing projects
Agenda Background Current testings Xpert MTB/RIF product PAGE | 1.
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Epistasis, Molecular mechanism, Importance Xudong Zou Prof. Yun-Dong Wu Dr. Zhiqiang Ye 8 th Nov
Why this paper Causal genetic variants at loci contributing to complex phenotypes unknown Rat/mice model organisms in physiology and diseases Relevant.
Evoluzione genetica di HIV ed evoluzione clinica della malattia AIDS: due aspetti correlati? Carlo Federico Perno.
Supervisor: VS 高志平 Reporter: R4 張妙而.  Mutations in nucleophosmin 1 ( NPM1 ) gene, one of the most common gene mutations (25%-30%) in AML  NPM1 mut co-occurs.
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Single Nucleotide Polymorphism And Association Studies Stat 115 Dec 12, 2006.
Identification of markers linked to Selenium tolerance genes
Using mouse genetics to understand human disease Mark Daly Whitehead/Pfizer Computational Biology Fellow.
SNP Applications statwww.epfl.ch/davison/teaching/Microarrays/snp.ppt.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Overview of Molecular Epidemiological Methods for the Subtyping and Comparison of Viruses Derek Wong
World Health Organization TB Case Definitions
Robert Ketcham & Sue Katz Creating a new problem space: Genetic Diversity of Mycobacterium tuberculosis.
Polymorphisms: Clinical Implications By Amr S. Moustafa, M.D.; Ph.D. Assistant Prof. & Consultant, Medical Biochemistry Dept. College of Medicine, KSU.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Physical Mapping I CIS 667 February 26, Physical Mapping A physical map of a piece of DNA tells us the location of certain markers  A marker is.
Computational Tools for Finding and Interpreting Genetic Variations Gabor T. Marth Department of Biology, Boston College
1 Introduction to Drug-Resistant TB Session 2. USAID TB CARE II PROJECT Classification of drug-resistant TB “Drug-resistant TB” is a general term to describe.
Analyzing DNA Differences PHAR 308 March 2009 Dr. Tim Bloom.
Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.
Summary Slide Presentation Are subtype differences important in HIV drug resistance? Lessells RJ, Katzenstein DK, de Oliveira T. Are subtype differences.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
The Complexities of Data Analysis in Human Genetics Marylyn DeRiggi Ritchie, Ph.D. Center for Human Genetics Research Vanderbilt University Nashville,
APPLICATION OF MOLECULAR MARKERS FOR CHARACTERIZATION OF LATVIAN CROP PLANTS Nils Rostoks University of Latvia Vienošanās Nr. 2009/0218/1DP/ /09/APIA/VIAA/099.
The Global Problem of Extensively Drug Resistant TB Peter M. Small, MD Institute for Systems Biology Bill and Melinda Gates Foundation February 17, 2008.
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
CS177 Lecture 10 SNPs and Human Genetic Variation
Development and Application of SNP markers in Genome of shrimp (Fenneropenaeus chinensis) Jianyong Zhang Marine Biology.
1 Gene Therapy Gene therapy: the attempt to cure an underlying genetic problem by insertion of a correct copy of a gene. –Tantalizingly simple and profound.
Experimental Design and Data Structure Supplement to Lecture 8 Fall
TB Methodologies Dr. John G. Magee Regional Reference Centre for Mycobacteriology Health Protection Agency Regional Laboratory, Newcastle upon Tyne.
Linkage and Mapping. Figure 4-8 For linked genes, recombinant frequencies are less than 50 percent.
Patterns of selection for or against amino acid change among different CD4 T-cell count progressor groups Michael Pina, Salomon Garcia Journal Club Presentation.
First Author: Radu Cristina Co-Authors: Stefan Anda Tripon Florin Crauciuc George Coordinators: Banescu Claudia, MD Demian Smaranda, MD The importance.
Lecture 6. Functional Genomics: DNA microarrays and re-sequencing individual genomes by hybridization.
Overview: Molecular Epi
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
Application of DNA-based methods to epidemiology of TB Marcel A. Behr Professor, McGill University Director, McGill Int. TB Centre
Diagnostic algorithms of TB case finding and their effect on TB epidemiology in Russian Regions Andrey Maryandyshev, Elena Nikishova Northern State Medical.
Computational Biology and Genomics at Boston College Biology Gabor T. Marth Department of Biology, Boston College
Analyzing DNA using Microarray and Next Generation Sequencing (1) Background SNP Array Basic design Applications: CNV, LOH, GWAS Deep sequencing Alignment.
Unit 1 – Living Cells.  The study of the human genome  - involves sequencing DNA nucleotides  - and relating this to gene functions  In 2003, the.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
Risheng Chen et al BMC Genomics
Press report 13/10/ publications selected.
Common variation, GWAS & PLINK
Gil McVean Department of Statistics
Polymerase Chain Reaction (PCR) and Its Applications
Comparison of WGA methods for genotyping fetal nucleated red blood cells for the application of non-invasive prenatal diagnosis Zhouwei Huang­­1, Angela.
Relationship between Genotype and Phenotype
Chasing TB Clusters – the role of molecular strain typing
Relationship between Genotype and Phenotype
Genome-wide Associations
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug- resistant tuberculosis and home-discharged patients with programmatically.
Relationship between Genotype and Phenotype
Chapter 7 Multifactorial Traits
T. M. Walker, M. Merker, T. A. Kohl, D. W. Crook, S. Niemann, T. E. A
Sequential Steps in Genome Mapping
M.W. Borgdorff, D. van Soolingen  Clinical Microbiology and Infection 
INTRODUCTION TO MOLECULAR GENETICS
Perspectives from Los Angeles County Tuberculosis Control Program
The future TB clinic. The future TB clinic. Sputum, saliva, and fecal samples are collected from patients for genome sequencing, SNP typing, or metagenomic.
Presentation transcript:

A ten-year evolution of a multidrug- resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( ) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker) 1 Unit of Typing & Genetics of Mycobacteria, Institut Pasteur de Tunis, Tunisia 2 Hôpital Régional de Menzel Bourguiba, Tunisia

MDR-TB outbreaks have been mainly described in HIV-positive institutionalized individuals Could MDR-TB outbreaks emerge and expand in a community strictly negative for HIV? HIV - community MDR-TB outbreak HIV + community fitness INH and RIF resistance-conferring mutations (MDR phenotype with fitness costs) Drug-sensitive and fitness-competent with an epidemic potential MTB clinical strain Acquisition of compensatory mutations fitness

ALGERIA Mediterranean sea LIBYA Tunisia An MDR-TB outbreak emerged in Tunisia and expanded in an HIV-negative context Bizerte N° Cases

The involved strains grow profisciently « in vitro » Affected young (mean age ~27 yrs), immuno-competent and HIV- negative individuals The outbreak expanded in the general community (non institutionalized) (Mardassi et al., EID 2005) The Tunisian MDR-TB outbreak major characteristics

Spoligoprofile IS6110 RFLP The Tunisian MDR-TB outbreak involved a Haarlem3 genotype clone harboring a rare rpoB secondary site mutation, V615M S531L V615M Mardassi et al., EID 2005

Development of a PCR-based test for the differentiation of the 12- and 11-banded profiles Namouchi & Mardassi, JMM Namouchi et al., JID 2010 GL-PCR Transposition site 12-banded11-banded Rv0403c (mmpS1) ++ Rv0755c : Rv0755A ++ Rv Rv1645c : Rv Rv1754c ++ Rv2015c ++ Rv Rv2352c (PPE38) ++ Rv2435c ++ Rv2813 : Rv Rv2818c ++ Rv3323c (moaX) ++ Spacer31* ++ Total 1312

Identification of the closest drug-sensitive pre-outbreak strain Namouchi et al., JID 2010

Carry out a comparative genomics analysis to better understand the molecualr basis undelying the epidemic phenotype Carry out an in-depth, 10-year spanning, genotypic analysis of the strains circulating in the epidemic region Appreciate over a 10-year period ( ) the clinical characteristics of the MDR-TB outbreak and the treatment outcome Objectives

The MDR-TB outbreak was more frequently associated with the 11-banded IS6110 RFLP profile 11-banded 12-banded

CharacteristicsAll outcomes N=45 (%) 11-banded IS6110 RFLP N=35 12-banded IS6110 RFLP N=10 Matched OR (95% CI) P value (Pearson's Chi- square test) Age (years,means) 29,7229,4630,63 0,774 <20 (4 (8,89%)311,19 (0,107-13,3)0, (60%)2161 (0,163-6,138)1 >405 (11,11%)410,857 (0,082-8,965)0,898 Male40 (88,89)3190,861 (0,085-8,706)0,899 Smear-positive15 (33,33%)9 (25,71%)6 (60%)4,333 (0,992-18,938)0,043* epidemiological link10 (22,22%)820,633 (0,107-3,733)0,612 Duration of treatment (months,means) 30,4 (67,56%)29,8332,4 0,81 Outcome category: Cure17 (37,78%)1430,6 (0,120-3,007)0,532 Failure6 (13,33%)510,657 (0,065-6,605)0,72 Relapse4 (8,89%)400,750 (0,614-0,916)0,257 Death9 (20%)544,6 (0,849-24,929)0,064 Aside from smear positivity, the 11- and 12- banded outbreak strains behave similarly

Treatment outcome:The outbreak proved difficult to treat

Age, meanSmear positivityRelapse Death (N=9) P = 0,082P = 0,197P = 0,002 Matched OR (95% CI) 4 (0,431-3,7) Matched OR (95% CI) 0,052 (0, ,492) %11,11%88,88% Death was significantly associated with relapse and chronic cases

H37Rv genome ( bp) rpoB rpsL rrs inhA girA gidB embB katGpncA eis Mutational analysis of drug resistance genes

Evolution of the MDR-TB outbreak based on mutations in drug resistance genes

Genome sequencing using the Illumina platform

Whole genome SNPs-based Venn diagram Drug sensitive pre- outbreak MDR Outbreak strains SNP: Single Nucleotide Polymorphism Whole genome LSPs-based Venn diagram Drug sensitive pre- outbreak MDR Outbreak strains LSP: Large Sequence Polymorphism (≥ 10 bp) Comparative genomics: Statistics

Haarlem3 (Hamburg) N= 89 Outbreak (San Francisco) N=09 Beijing (Uzbekistan) N=02 5 SNPs + 5 short deletions 7 SNPs+ 0 indels130 SNPs+ 1 large deletion (Andreas Roetzer,2013)Midori Kato-Maeda, 2013)(Niemann S, 2009) Few Indel events differentiate other outbreak strains described worldwide

Indels contributed significantly to the clonal diversification of the MDR-TB outbreak-associated strains : TUN : TUN : TUN : TUN : TUN : TUN : TUN233-02

Genome-wide-based Maximum Likelihood phylogenetic tree

What have we learned from microgenomics on the biology of the MDR-TB outbreak?

Comparative genomics coupled to structural analysis disclosed the possible role of the rpoB secondary mutation, V615M, in fitness cost compensation No putative compensatory mutations either in rpoC or in rpoA coud be identified V615M maps to the flexible bridge helix structure which interact with DNA

The outbreak-restricted secondary site rpoB mutation, V615M, did indeed restore the fitness costs of S531L Engineered mutant BCG harboring V615M +S531L and WT-BCG display comparable fitness Engineered mutant BCG harboring V615M +S531L grows as efficiently as WT-BCG

1081 pb 400 pb 680 pb An in-frame deletion in the ferredoxin gene is likely to be critical to the epidemic potential of the Tunisian MDR outbreak strain

II 1.9 kb I 1 kb 4.7 kb Shared, outbreak-restricted, deletions to be further explored by functional genetics

Phylogenomics confirm the relatedness of the Tunisian MDR- TB outbreak strain with the epidemic CDC1551 and C strains The genome of the MDR-TB outbreak strain appears to evolve rapidly, mainly through frequent indel events Rationale comparative genomics identified key deletion events which could have contributed to the epidemic phenotype of the Tunisian MDR outbreak strain Main outputs from comparative genomics

An in-depth snapshot of the molecular epidemiology of the M. tuberculosis Haarlem genotype in the epidemic region

All Haarlem strains and variants co-evolving with the MDR-TB outbreak ( ) were included in a MIRU-VNTR24 typing analyses

The MTB Haarlem strain family, northern Tunisia, is likely to be intrinsically epidemic and genetically unstable N=35 N=30 N=53 N=45 MDR-TB outbreak Recent transmission rate: 86%

Conclusions MDR-TB outbreaks can emerge and successfully expand in a HIV- negative context The Tunisian MDR-TB outbreak benefited of an intrinsic epidemic potential coupled to a rapid genomic evolution, mainly through indels Evolution to the XDR phenotype is likely to be a associated with the genetic trait of the involved strain rather than treatment default